4 Summary of Prior T reatment for Malignant Disease (Full Analysis Population) Table 5 In-text table (will refer to listing) Summary of Prior Lines of Chemotherapy/Other Therapy (Full Analysis Population) Table 7 In-text table (will refer to listing) Protocol D eviations per C riterion Table 9 14.3.1 Overview of Treatment Emergent Adverse Events (Safety Population) Table 8 14.3.2 Frequency of All Adverse Events (Safety Population) N/A: based on Table 8 14.3.3 Frequency of Pre -Treatment Adverse Events (Safety Population) N/A: based on Table 8 14.3.4 Frequency of Treatment Emergent Adverse Events (Safety Population) N/A: based on Table 8 14.3.5 Frequency of Treatment Emergent Serious Adverse Events (Safety Population) SM.TEMP.013 version 5 CRUKD/17/003 RAP Version: 2.0 09Mar2023 FINAL 28 N/A: based on Table 8 14.3.6 Frequency of Related Treatment Emergent Adverse Events (Safety Population) Table 10 14.3.7 Frequency of Treatment Emergent A dverse Event s and Related Treatment Emergent Adverse Events by Worst CTCAE Grade within an Episode (Safety Population) Table 11 14.3.8 Frequency of Patients with Treatment Emergent Adverse Events and Related Treatment Emergent Adverse Events by Worst CTCAE Grade within an Episode (Safety Population) Table 1 2 14.3.9 Summary of Injection Site Reactions by Grade and Vaccination Number (Safety Population) Table 1 3 14.2.1 Overall R esponse (Response Population) Table 1 4 14.2.2 Summary of Survival (Safety Population) Table 1 5 14.2.3 Two Year Survival (Safety Population) 7. PRESENTATION OF RESULTS IN CLINICALTRIALS.GOV INCLUDING ADDITIONAL TABLES The following information will be used for presentation and upload of trial data on Clinical Trials.gov.